Pulmonx Corporation (NASDAQ: LUNG) reported Q4 EPS of ($0.33), $0.12 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $23.8 million versus the consensus estimate of $22.29 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.